The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 <i>In Vivo</i>

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center">Inhibitory rate (%)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Model control</td><td class="align_center">—</td></tr><tr><td class="align_left">Tan IIA</td><td class="align_center">32.77</td></tr><tr><td class="align_left">ADM</td><td class="align_center">60.96</td></tr><tr><td class="align_left">Tan IIA + ADM</td><td class="align_center">73.18</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The inhibitory rate following treatment in four groups.</div>

Advances in Medicine

tab1

Table 1

Table 1: The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 <i>In Vivo</i> 

Table 1 | The Synergistic Antitumor Effect of Tanshinone IIA Plus Adriamycin on Human Hepatocellular Carcinoma Xenograft in BALB/C Nude Mice and Their Influences on Cytochrome P450 CYP3A4 In Vivo 